Table 1A.
Behçet’s Disease Patients demographics for saliva and serum analysis.
| Demographic and Clinical Features of Behcet’s Patients (N=20) | ||
|---|---|---|
| Mean Age ±SD, Years | 37.3±9.25 | |
| Gender | Number (N) | % |
| Male | 7 | 35 |
| Female | 13 | 65 |
| Clinical Features | ||
| Oral Ulcers | 9 | 45 |
| Genital Ulcers | 4 | 20 |
| Eye Lesions | 3 | 15 |
| Skin Lesions | 3 | 15 |
| Joint Involvement | 9 | 45 |
| Erythema Nodosum | 2 | 10 |
| Vascular Involvement | 1 | 5 |
| CNS | 2 | 10 |
| Relapsed | 7 | 35 |
| Treatment | ||
| Prednisolone (PRED) | 4 | 20 |
| Azathioprine (AZA) | 2 | 10 |
| Colchicine (COLC) | 3 | 15 |
| PRED + AZA | 2 | 10 |
| PRED + COLC | 1 | 5 |
| PRED + COLC + AZA | 3 | 15 |
| AZA + COLC | 1 | 5 |
| Cyclosporine A + COLC | 1 | 5 |
| No Treatment | 3 | 15 |